The U.S. Food and Drug Administration warned physicians on Wednesday that two chemicals used to conduct cardiovascular stress tests can cause heart attacks and death, and it suggested resuscitation ...

JERUSALEM — Teva Pharmaceutical Industries has become the first to launch a generic drug for treating certain heart patients, the company said. Teva announced the launch of adenosine injection, a ...

FDA: Stress Test Agents Linked to Possible Heart Attack, Death The FDA is warning healthcare professionals of the rare but serious risk of heart attack and death associated with the use of Lexiscan ...

WASHINGTON, Nov. 20 (UPI) -- The U.S. Food and Drug Administration warns doctors of the rare but serious risk of heart attack and death with use of the cardiac nuclear stress test agents. The cardiac ...

Please provide your email address to receive an email when new articles are posted on . The FDA has issued a safety announcement warning health care professionals of rare but serious risk for MI and ...

> A Florida hospital has sued Astellas Pharma over Adenoscan, a drug given to people unable to run on a treadmill during cardiac stress tests, because the drugmaker argues hospitals would violate a ...

SILVER SPRING, Md. -- Two agents used in cardiac nuclear stress tests may carry a greater risk of heart attack and death than previously believed, the FDA said Wednesday. "When reported, these adverse ...

Astellas Pharma, King Pharmaceuticals (KG) and Teva Pharmaceutical Industries (TEVA) announce that US subsidiaries of Astellas, along with Item Development A.B and KB have executed settlement ...